154
vs
ABT
154
ABT
Over the past 12 months, Inmode Ltd has underperformed ABT, delivering a return of -25% compared to the ABT's 15% drop.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
154
ABT
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Inmode Ltd
F:154
|
13.24
EUR
|
|||||
|
Abbott Laboratories
NYSE:ABT
|
109.23
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
154, ABT
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
|
Inmode Ltd
Revenue
|
|||||||||||
|
|
Abbott Laboratories
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
154, ABT
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
|
Inmode Ltd
F:154
|
|||||||||
|
|
Abbott Laboratories
NYSE:ABT
|
|||||||||
Compare company's free cash flow with its competitors.
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
154, ABT
Performance By Year
154, ABT
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
